Published in Exp Eye Res on June 13, 2006
An alpha 2 collagen VIII transgenic knock-in mouse model of Fuchs endothelial corneal dystrophy shows early endothelial cell unfolded protein response and apoptosis. Hum Mol Genet (2011) 1.29
L450W and Q455K Col8a2 knock-in mouse models of Fuchs endothelial corneal dystrophy show distinct phenotypes and evidence for altered autophagy. Invest Ophthalmol Vis Sci (2013) 0.88
Assessment of postnatal corneal development in the C57BL/6 mouse using spectral domain optical coherence tomography and microwave-assisted histology. Exp Eye Res (2011) 0.88
Abnormal corneal endothelial maturation in collagen XII and XIV null mice. Invest Ophthalmol Vis Sci (2013) 0.80
Cell pattern in adult human corneal endothelium. PLoS One (2011) 0.78
Cryopreservation and long-term culture of transformed murine corneal endothelial cells. Graefes Arch Clin Exp Ophthalmol (2011) 0.78
Age-related dystrophic changes in corneal endothelium from DNA repair-deficient mice. Aging Cell (2013) 0.78
MicroRNAs are differentially expressed in ulcerative colitis and alter expression of macrophage inflammatory peptide-2 alpha. Gastroenterology (2008) 3.29
A murine model of chronic inflammation-induced intestinal fibrosis down-regulated by antisense NF-kappa B. Gastroenterology (2003) 2.53
Genome-wide gene expression differences in Crohn's disease and ulcerative colitis from endoscopic pinch biopsies: insights into distinctive pathogenesis. Inflamm Bowel Dis (2007) 1.94
Interface fluid syndrome in human eye bank corneas after LASIK: causes and pathogenesis. Ophthalmology (2007) 1.89
Increased endothelial cell density in the paracentral and peripheral regions of the human cornea. Am J Ophthalmol (2003) 1.79
Review of corneal endothelial specular microscopy for FDA clinical trials of refractive procedures, surgical devices, and new intraocular drugs and solutions. Cornea (2008) 1.68
Reduced expression of the small leucine-rich proteoglycans, lumican, and decorin is associated with poor outcome in node-negative invasive breast cancer. Clin Cancer Res (2003) 1.67
A syndrome of joint laxity and impaired tendon integrity in lumican- and fibromodulin-deficient mice. J Biol Chem (2002) 1.64
Ocular drug delivery. Expert Opin Drug Deliv (2006) 1.61
Depth-dependent cohesive tensile strength in human donor corneas: implications for refractive surgery. J Refract Surg (2008) 1.58
Toxic anterior segment syndrome. J Cataract Refract Surg (2006) 1.53
Mechanisms of corneal tissue cross-linking in response to treatment with topical riboflavin and long-wavelength ultraviolet radiation (UVA). Invest Ophthalmol Vis Sci (2009) 1.41
Evaluation of endothelial mucin layer thickness after phacoemulsification with next generation ophthalmic irrigating solution. Cornea (2008) 1.39
Lumican regulates corneal inflammatory responses by modulating Fas-Fas ligand signaling. Invest Ophthalmol Vis Sci (2005) 1.37
Cohesive tensile strength of human LASIK wounds with histologic, ultrastructural, and clinical correlations. J Refract Surg (2005) 1.33
An alpha 2 collagen VIII transgenic knock-in mouse model of Fuchs endothelial corneal dystrophy shows early endothelial cell unfolded protein response and apoptosis. Hum Mol Genet (2011) 1.29
A novel role of the lumican core protein in bacterial lipopolysaccharide-induced innate immune response. J Biol Chem (2007) 1.26
Subnormal cytokine profile in the tear fluid of keratoconus patients. PLoS One (2011) 1.23
Corneal ectasia after excimer laser keratorefractive surgery: histopathology, ultrastructure, and pathophysiology. Ophthalmology (2008) 1.22
Lumican suppresses cell proliferation and aids Fas-Fas ligand mediated apoptosis: implications in the cornea. Exp Eye Res (2004) 1.22
Suprachoroidal drug delivery to the back of the eye using hollow microneedles. Pharm Res (2010) 1.20
Differential expression of inflammatory and fibrogenic genes and their regulation by NF-kappaB inhibition in a mouse model of chronic colitis. J Immunol (2007) 1.20
Histologic, ultrastructural, and immunofluorescent evaluation of human laser-assisted in situ keratomileusis corneal wounds. Arch Ophthalmol (2005) 1.18
Biomechanical and wound healing characteristics of corneas after excimer laser keratorefractive surgery: is there a difference between advanced surface ablation and sub-Bowman's keratomileusis? J Refract Surg (2008) 1.17
Subconjunctival carboplatin in fibrin sealant in the treatment of transgenic murine retinoblastoma. Ophthalmology (2005) 1.16
Effect of circulation on the disposition and ocular tissue distribution of 20 nm nanoparticles after periocular administration. Mol Vis (2008) 1.15
Extracellular matrix lumican deposited on the surface of neutrophils promotes migration by binding to beta2 integrin. J Biol Chem (2009) 1.13
Evidence suggesting the existence of stem cells for the human corneal endothelium. Mol Vis (2005) 1.12
Stem cell markers in the human posterior limbus and corneal endothelium of unwounded and wounded corneas. Mol Vis (2007) 1.10
Neonatal corneal stromal development in the normal and lumican-deficient mouse. Invest Ophthalmol Vis Sci (2003) 1.10
Long-term histopathologic findings in human corneal wounds after refractive surgical procedures. Am J Ophthalmol (2005) 1.08
Targeted administration into the suprachoroidal space using a microneedle for drug delivery to the posterior segment of the eye. Invest Ophthalmol Vis Sci (2012) 1.07
Intrascleral drug delivery to the eye using hollow microneedles. Pharm Res (2008) 1.07
Multistate outbreak of toxic anterior segment syndrome, 2005. J Cataract Refract Surg (2008) 1.06
Antibody blockade of junctional adhesion molecule-A in rabbit corneal endothelial tight junctions produces corneal swelling. Invest Ophthalmol Vis Sci (2006) 1.06
Fas-mediated apoptosis regulates the composition of peripheral alphabeta T cell repertoire by constitutively purging out double negative T cells. PLoS One (2008) 1.05
Retinal function after subconjunctival injection of carboplatin in fibrin sealant. Retina (2004) 1.05
Enzymatic detergents and toxic anterior segment syndrome. Ophthalmology (2013) 1.05
Pharmacokinetics of intraocular drug delivery by periocular injections using ocular fluorophotometry. Invest Ophthalmol Vis Sci (2007) 1.05
Coated microneedles for drug delivery to the eye. Invest Ophthalmol Vis Sci (2007) 1.04
Effect of mitomycin C on the corneal endothelium when used for corneal subepithelial haze prophylaxis following photorefractive keratectomy. J Refract Surg (2007) 1.01
Transforming growth factor-β signaling pathway activation in Keratoconus. Am J Ophthalmol (2011) 1.00
Influence of dosage form on the intravitreal pharmacokinetics of diclofenac. Invest Ophthalmol Vis Sci (2009) 1.00
Retracted Sclera-choroid-RPE transport of eight β-blockers in human, bovine, porcine, rabbit, and rat models. Invest Ophthalmol Vis Sci (2011) 1.00
Barriers to glaucoma drug delivery. J Glaucoma (2008) 0.99
Fibromodulin regulates collagen fibrillogenesis during peripheral corneal development. Dev Dyn (2010) 0.98
Modeling of corneal and retinal pharmacokinetics after periocular drug administration. Invest Ophthalmol Vis Sci (2008) 0.98
A novel bioerodible deep scleral lamellar cyclosporine implant for uveitis. Invest Ophthalmol Vis Sci (2006) 0.98
Ex vivo confocal microscopy of human LASIK corneas with histologic and ultrastructural correlation. Ophthalmology (2005) 0.98
Transscleral diffusion of carboplatin: an in vitro and in vivo study. Arch Ophthalmol (2002) 0.96
Differential gene expression patterns of the developing and adult mouse cornea compared to the lens and tendon. Exp Eye Res (2008) 0.96
Interface fluid syndrome in laser in situ keratomileusis after complicated trabeculectomy. J Cataract Refract Surg (2006) 0.96
Drug delivery through the sclera: effects of thickness, hydration, and sustained release systems. Exp Eye Res (2004) 0.95
Expression of JAM-A in the human corneal endothelium and retinal pigment epithelium: localization and evidence for role in barrier function. Invest Ophthalmol Vis Sci (2007) 0.95
Sphere formation from corneal keratocytes and phenotype specific markers. Exp Eye Res (2011) 0.94
Anatomic alterations in aging and age-related diseases of the eye. Invest Ophthalmol Vis Sci (2013) 0.94
In vitro human scleral permeability of fluorescein, dexamethasone-fluorescein, methotrexate-fluorescein and rhodamine 6G and the use of a coated coil as a new drug delivery system. J Ocul Pharmacol Ther (2002) 0.94
The keratoconus corneal proteome: loss of epithelial integrity and stromal degeneration. J Proteomics (2013) 0.94
Subconjunctival topotecan in fibrin sealant in the treatment of transgenic murine retinoblastoma. Invest Ophthalmol Vis Sci (2008) 0.93
Drug and gene delivery to the back of the eye: from bench to bedside. Invest Ophthalmol Vis Sci (2014) 0.93
Particle-stabilized emulsion droplets for gravity-mediated targeting in the posterior segment of the eye. Adv Healthc Mater (2014) 0.92
Suprachoroidal delivery in a rabbit ex vivo eye model: influence of drug properties, regional differences in delivery, and comparison with intravitreal and intracameral routes. Mol Vis (2013) 0.91
Extracellular matrix protein lumican regulates inflammation in a mouse model of colitis. Inflamm Bowel Dis (2011) 0.90
Neonatal development of the corneal stroma in wild-type and lumican-null mice. Invest Ophthalmol Vis Sci (2006) 0.89
Extracellular matrix protein lumican promotes clearance and resolution of Pseudomonas aeruginosa keratitis in a mouse model. PLoS One (2013) 0.89
In vitro sustained human transscleral drug delivery of fluorescein-labeled dexamethasone and methotrexate with fibrin sealant. Curr Eye Res (2005) 0.89
L450W and Q455K Col8a2 knock-in mouse models of Fuchs endothelial corneal dystrophy show distinct phenotypes and evidence for altered autophagy. Invest Ophthalmol Vis Sci (2013) 0.88
Mucoadhesive microdiscs engineered for ophthalmic drug delivery: effect of particle geometry and formulation on preocular residence time. Invest Ophthalmol Vis Sci (2008) 0.88
Histologic and ultrastructural findings in human corneas after successful laser in situ keratomileusis. Arch Ophthalmol (2002) 0.87
Effects of enzymatic sterilization detergents on the corneal endothelium. Arch Ophthalmol (2002) 0.86
Cryopreservation and lentiviral-mediated genetic modification of human primary cultured corneal endothelial cells. Invest Ophthalmol Vis Sci (2007) 0.86
Proteome profiling of wild type and lumican-deficient mouse corneas. J Proteomics (2011) 0.85
Outbreak of toxic anterior segment syndrome following cataract surgery associated with impurities in autoclave steam moisture. Infect Control Hosp Epidemiol (2006) 0.85
Recommended practices for cleaning and sterilizing intraocular surgical instruments. J Cataract Refract Surg (2007) 0.85
Pharmacokinetics of intraocular drug delivery of Oregon green 488-labeled triamcinolone by subtenon injection using ocular fluorophotometry in rabbit eyes. Invest Ophthalmol Vis Sci (2008) 0.84
Extracellular matrix lumican promotes bacterial phagocytosis, and Lum-/- mice show increased Pseudomonas aeruginosa lung infection severity. J Biol Chem (2012) 0.84
Histopathological analysis of post-laser-assisted in situ keratomileusis corneal ectasia with intrastromal corneal ring segments. Arch Ophthalmol (2005) 0.83
A novel antimicrobial peptidoglycan recognition protein in the cornea. Invest Ophthalmol Vis Sci (2009) 0.83
The influence of intraocular pressure on the transscleral diffusion of high-molecular-weight compounds. Invest Ophthalmol Vis Sci (2005) 0.83
Proposed new classification scheme for chemical injury to the human eye. Regul Toxicol Pharmacol (2006) 0.82
Viscoelastic protection from endothelial damage by air bubbles. J Cataract Refract Surg (2002) 0.82
Influence of choroidal neovascularization and biodegradable polymeric particle size on transscleral sustained delivery of triamcinolone acetonide. Int J Pharm (2012) 0.81
In vivo ocular fluorophotometry: delivery of fluoresceinated dextrans via transscleral diffusion in rabbits. Invest Ophthalmol Vis Sci (2011) 0.81
Scleral permeability of a small, single-stranded oligonucleotide. J Ocul Pharmacol Ther (2004) 0.81
Inhibition of Fas ligand in NOD mice unmasks a protective role for IL-10 against insulitis development. Am J Pathol (2011) 0.81
Human scleral diffusion of anticancer drugs from solution and nanoparticle formulation. Pharm Res (2009) 0.81
Corneal epithelial testing strategies for safety evaluation of ophthalmic formulations. Cutan Ocul Toxicol (2007) 0.80
Measurement and prediction of lateral diffusion within human sclera. Invest Ophthalmol Vis Sci (2006) 0.80
Transscleral permeability of fluorescent-labeled antibiotics. J Ocul Pharmacol Ther (2005) 0.79
A cellular model for the investigation of Fuchs' endothelial corneal dystrophy. Exp Eye Res (2011) 0.79
Chronic pain after Intacs implantation. J Cataract Refract Surg (2006) 0.79
The disposition and bioavailability of 35S-GSH from 35S-GSSG in BSS PLUS in rabbit ocular tissues. J Ocul Pharmacol Ther (2004) 0.79
Correlation between epithelial ingrowth and basement membrane remodeling in human corneas after laser-assisted in situ keratomileusis. Arch Ophthalmol (2010) 0.79
Mucoadhesive microparticles in a rapidly dissolving tablet for sustained drug delivery to the eye. Invest Ophthalmol Vis Sci (2011) 0.78
Keratan sulfate and chondroitin/dermatan sulfate in maximally recovered hypocellular stromal interface scars of postmortem human LASIK corneas. Invest Ophthalmol Vis Sci (2006) 0.78
Corneal endothelium after refractive surgery. J Cataract Refract Surg (2011) 0.78
Transscleral permeability and intraocular concentrations of cisplatin from a collagen matrix. J Control Release (2003) 0.78
Proteomics of human aqueous humor. OMICS (2015) 0.78